Research Article
Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux Disease
Table 1
Demographics and baseline characteristics.
| Parameters | Control group | Group A | Group B | Group C | Group D |
| Patients number | 2840 | 818 | 402 | 72 | 16 |
| Mean age (range) | 50.2 ±18.9 | 46.9±17.8 | 47.9±17.7 | 53±18.7 | 65±15.6 |
| Male (%) | 46.5 | 45 | 54 | 64 | 62.5 |
| Body mass index | 29.7 | 29.5 | 29.5 | 29.4 | 28.6 |
| Active smokers (%) | 47.2 | 77.7 | 75.3 | 88.8 | 75 |
| Alcohol consumers (%) | 3.7 | 4 | 3.4 | 4.1 | 18.7 |
| Use of statins (%) | 15.8 | 8.6 | 6.4 | 9.7 | 6.2 |
| Use of NSAIDS (%) | 27.1 | 34.2 | 32.1 | 37.5 | 25 |
| Use of PPI (%) | 46 | 69 | 68 | 79 | 63 |
| Presence of hiatal hernia (%) | 28.5 | 40.9 | 41.5 | 45.8 | 43.7 |
|
|